CHRISTINA OSBORNE: Open Payments
NPI 1508596966 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 52 payments from 15 companies in 2025. Trend: 2023 $1,266 · 2024 $1,762 · 2025 $1,511
Food & beverage: $1,511
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $682 |
| UCB, Inc. | 6 | $183 |
| ABBVIE INC. | 8 | $176 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| PFIZER INC. | 4 | $83 |
| Alexion Pharmaceuticals, Inc. | 2 | $52 |
| Fresenius Kabi USA, LLC | 2 | $40 |
| Radius Health, Inc. | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
Products named: UPLIZNA, Bimzelx, RINVOQ, TAVNEOS, XELJANZ, COSENTYX, STRENSIQ, SKYRIZI.
Industry payments across NY — which companies pay providers there.
